We are live on ! Find out more
HSA

Hussman Strategic Advisors Portfolio holdings

AUM $434M
1-Year Est. Return 19.64%
This Fund
S&P 500
This Quarter Est. Return
+8.02%
1 Year Est. Return
+19.64%
3 Year Est. Return
+41.56%
5 Year Est. Return
+34.45%
10 Year Est. Return
+261.65%
AUM
$434M
AUM Growth
-$28.5M
Cap. Flow
-$39M
Cap. Flow %
-8.97%
Top 10 Hldgs %
10.4%
Holding
334
New
66
Increased
40
Reduced
42
Closed
103

Top Buys

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$4.08M
2
UI icon
Ubiquiti
UI
+$3.96M
3
CRM icon
Salesforce
CRM
+$3.69M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.57M
5
GMED icon
Globus Medical
GMED
+$3.57M

Top Sells

Rank Stock Value
1
CORT icon
Corcept Therapeutics
CORT
+$5.08M
2
SEZL
Sezzle
SEZL
+$3.99M
3
PSIX
Power Solutions International
PSIX
+$3.84M
4
QLYS icon
Qualys
QLYS
+$3.69M
5
PGNY icon
Progyny
PGNY
+$3.57M

Sector Composition

Rank Sector Weight
1 Healthcare 23.08%
2 Technology 17.18%
3 Consumer Discretionary 15.3%
4 Financials 9.77%
5 Consumer Staples 9.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RRR icon
151
Red Rock Resorts
RRR
$3.15B
$1.37M 0.31%
+21,000
New +$1.19M
TNK icon
152
Teekay Tankers
TNK
$3.49B
$1.36M 0.31%
21,000
– –
MNR icon
153
Mach Natural Resources
MNR
$1.82B
$1.33M 0.31%
+105,000
New +$1.4M
TARS icon
154
Tarsus Pharmaceuticals
TARS
$3.63B
$1.32M 0.3%
21,000
+4,200
+25% +$268K
PAHC icon
155
Phibro Animal Health
PAHC
$1.43B
$1.32M 0.3%
42,000
– –
ACN icon
156
Accenture
ACN
$116B
$1.31M 0.3%
+10,500
New +$1.82M
IBRX icon
157
ImmunityBio
IBRX
$8.38B
$1.29M 0.3%
+147,000
New +$1.11M
BAH icon
158
Booz Allen Hamilton
BAH
$9.43B
$1.27M 0.29%
+21,000
New +$1.6M
DPZ icon
159
Domino's
DPZ
$9.97B
$1.24M 0.29%
4,200
-2,100
-33% -$691K
GLOB icon
160
Globant
GLOB
$1.66B
$1.22M 0.28%
+42,000
New +$1.68M
UNIT
161
Uniti Group
UNIT
$2.32B
$1.2M 0.28%
+105,000
New +$1.19M
LULU icon
162
lululemon athletica
LULU
$10.6B
$1.2M 0.28%
+10,500
New +$1.4M
SJM icon
163
J.M. Smucker
SJM
$13.2B
$1.18M 0.27%
10,500
– –
FLNG icon
164
FLEX LNG
FLNG
$1.74B
$1.18M 0.27%
42,000
– –
RPRX icon
165
Royalty Pharma
RPRX
$26B
$1.18M 0.27%
21,000
– –
UAN icon
166
CVR Partners
UAN
$1.4B
$1.17M 0.27%
+10,500
New +$1.29M
MAT icon
167
Mattel
MAT
$3.76B
$1.17M 0.27%
+84,000
New +$1.23M
CRC icon
168
California Resources
CRC
$4.84B
$1.16M 0.27%
22,000
+21,000
+2,100% +$1.29M
FHI icon
169
Federated Hermes
FHI
$4.23B
$1.16M 0.27%
21,000
+10,500
+100% +$594K
UTHR icon
170
United Therapeutics
UTHR
$21.4B
$1.14M 0.26%
+2,100
New +$1.18M
LUMN icon
171
Lumen
LUMN
$6.88B
$1.13M 0.26%
+147,000
New +$1.29M
MMS icon
172
Maximus
MMS
$3.02B
$1.13M 0.26%
21,000
-21,000
-50% -$1.31M
MDGL icon
173
Madrigal Pharmaceuticals
MDGL
$12.2B
$1.13M 0.26%
+2,100
New +$1.08M
LCII icon
174
LCI Industries
LCII
$2.12B
$1.11M 0.26%
+10,500
New +$1.15M
INVX
175
Innovex International
INVX
$2.05B
$1.04M 0.24%
42,000
– –
5 6
7
8 9

Similar funds

NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
DCM
Divisar Capital Management San Francisco, California $434M AUM 170.22% 1-Year Est. Return
SCP
Seafarer Capital Partners Larkspur, California $434M AUM 22.8% 1-Year Est. Return
NRC
New Republic Capital Charlotte, North Carolina $434M AUM 31.16% 1-Year Est. Return
CEI
Clark Estates Inc New York $434M AUM 15% 1-Year Est. Return
CFG
Carr Financial Group Worcester, Massachusetts $434M AUM 28.34% 1-Year Est. Return
CAAM
Cape Ann Asset Management London, United Kingdom $434M AUM 68.57% 1-Year Est. Return
OCPWS
One Charles Private Wealth Services Hingham, Massachusetts $434M AUM 22.37% 1-Year Est. Return

Hussman Strategic Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, Hussman Strategic Advisors held 334 positions worth $434M, down 6.2% from $463M the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Hussman Strategic Advisors withdrew a net $39M in Q2 2026, closing 103 positions and reducing 42 holdings. Its most notable exit was Corcept Therapeutics, an estimated $5.08M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Hussman Strategic Advisors opened a new position in Salesforce worth $3.29M.

  • Hussman Strategic Advisors's largest Q2 2026 buy was Salesforce: 21,000 shares worth $3.29M.
  • Hussman Strategic Advisors added most to PepsiCo in Q2 2026, an estimated $4.08M increase.
  • Hussman Strategic Advisors's biggest Q2 2026 reduction was Concentrix, cutting an estimated $2.74M.
  • Hussman Strategic Advisors fully exited Corcept Therapeutics in Q2 2026, selling an estimated $5.08M.
  • Hussman Strategic Advisors's ten largest holdings make up 10% of its $434M portfolio in Q2 2026.
  • Hussman Strategic Advisors opened 66 new positions and closed 103 in Q2 2026.
  • Hussman Strategic Advisors's portfolio value fell 6.2% quarter-over-quarter to $434M.

Based on Hussman Strategic Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.